Miguel Martín

机构：Instituto de Salud Carlos III, Hospital General Universitario Gregorio Marañón, Centro de Investigación Biomédica en Red de Cáncer, GEICAM – Spanish Breast Cancer Group, Universitat Politècnica de València · ORCID：0000-0001-9237-3231

发表论文 1239 篇 · 总被引 49440 次 · h-index 108

代表论文

• HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer (2025 · Journal of Clinical Oncology · 被引 10)
• Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2− Highly Proliferative Breast Cancer (2025 · Clinical Cancer Research · 被引 4)
• Environmental Performance of Mature Precast Slabs in Permeable Pavements: Hydraulic Functionality and Pollutant Retention Under Real-Life Conditions (2026 · Water · 被引 1)
• Breast cancer incidence and survival by subtype, stage at diagnosis and socioeconomic deprivation among young women in the Community of Madrid, Spain (2025 · International Journal of Cancer · 被引 1)
• HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility (2026 · ESMO Open)
• Influence of permeable pavement design and hydraulic management on runoff treatment capacity: Addition of adsorbent drinking water treatment sludge and water reuse potential (2026 · Journal of Water Process Engineering)